Please complete the CAPTCHA to continue
@ivybiomedical.com
✓
2 phones found area 617
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
David Ataide is listed as Former CEO at GEHC | Board Member | Advisor | Investor at Opticyte, based in Greater Boston, United States, United States. AeroLeads shows a work email signal at ivybiomedical.com, phone signal with area code 617, and a matched LinkedIn profile for David Ataide.
David Ataide previously worked as Founder | Principal at Dra Medical Advisors and Member, Board of Directors at Opticyte. David Ataide holds Msn, Critical Care & Administration from University Of California, San Francisco.
This section adds company-level context without repeating David Ataide's masked contact details.
AeroLeads found 1 current-domain work email signal for David Ataide. Compare company email patterns before reaching out.
Accomplished global healthcare executive. Former CEO, GE Patient Monitoring & Dx Cardiology; Chief Marketing Officer, Philips Medical NV; Chairman, Intelesens Healthcare. Currently Director at Opticyte, BrainTemp Inc. and Ivy Biomedical. M & A Advisory Board Member at MedWorld Advisors.Core expertise in general management, marketing, channels of distribution and business development. Domain expertise in a wide variety of medical device, imaging and healthcare I.T. markets.
Listed skills include Medical Devices, Cross Functional Team Leadership, Healthcare Information Technology, Product Development, and 23 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Medical Device Consulting: Strategy development, product positioning & differentiation, commercialization including product launch & channel development, partnerships & alliances, interim operating assistance.
Seattle, Washington, US
Opticyte is a medical device start-up that was founded to address one of healthcare’s most compelling unmet needs, the early detection and treatment of organ failure and sepsis. Our non-invasive Cell 02 Monitor identifies oxygen deficiency within organ cells, allowing clinicians to immediately recognize the earliest stages of organ failure and begin life.
BrainTemp is a privately held medical device company founded to address a vital yet often-unrecognized need in the care and treatment of critically ill patients… the inability to safely measure and monitor brain temperature. Our first product, BTNeo, recently received FDA De Novo clearance for non-invasive monitoring of brain temperature in neonates. We do.
Branford, CT, US
Ivy Biomedical Systems is an industry leading innovator focused on cardiac and respiratory gating solutions for diagnostic Nuclear Medicine (NM), Molecular Imaging (MI), Computed Tomography (CT), and Magnetic Resonance Imaging (MR). Other applications include ablation and lithotripsy. With over 60,000 trigger monitors and modules sold to date, Ivy.
Boston, MA, US
MedWorld Advisors is a boutique mergers and acquisitions firm that focuses on small to medium size Medical Device, MedTech, BioTech, Life Sciences and Digital Health companies. The practice includes Strategic Planning, Enterprise Value Improvement and both Sell and Buy-Side M&A.
Kfar Saba, IL
A pre-commercial stage medical device company dedicated to non-invasive monitoring of the brain. Received FDA clearance for a unique device that simultaneously and non-invasively measures blood flow and oxygen saturation, the combination of which is key to understanding auto-regulation and tissue perfusion.
Belfast, Antrim, GB
Completed a successful exit with the sale of Intelesens to UltraLinq Healthcare, the Connected Healthcare Platform of Renew Health Limited. Spun out of the University of Ulster, Intelesens innovations are disrupting the conventional models for monitoring vital signs in the hospital and home. The company's intelligent, non-invasive wearable monitors make.
San Jose, CA, US
A development stage company pioneering breakthrough technology focused on making non-invasive glucose monitoring a reality.
Chicago, US
Operating Partner for GE's venture fund. Identified & diligenced opportunities. Served as board member for select portfolio companies.
Chicago, US
Patient Monitoring & Dx Cardiology: P&L leader for $1.3B global business. General Management responsibilities included R&D, Marketing, Quality, Regulatory, Supply Chain and Sales/Distribution/Service.
Quick answers generated from the profile data available on this page.
David Ataide works for Opticyte.
David Ataide is listed as Former CEO at GEHC | Board Member | Advisor | Investor at Opticyte.
AeroLeads has found 1 work email signal at @ivybiomedical.com for David Ataide at Opticyte.
AeroLeads has found 2 phone signal(s) with area code 617 for David Ataide at Opticyte.
David Ataide is based in Greater Boston, United States, United States while working with Opticyte.
David Ataide has worked for Dra Medical Advisors, Opticyte, Braintemp Inc., Ivy Biomedical Systems, and Medworld Advisors.
You can use AeroLeads to view verified contact signals for David Ataide at Opticyte, including work email, phone, and LinkedIn data when available.
David Ataide holds Msn, Critical Care & Administration from University Of California, San Francisco.
David Ataide is listed with skills including Medical Devices, Cross Functional Team Leadership, Healthcare Information Technology, Product Development, Healthcare, Cardiology, Strategy, and Leadership.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts